OTTAWA, Ontario, Aug. 16, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (” Tetra ” or the ” Company “) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that its common shares have been approved for trading on the TSX Venture Exchange and that it has applied for voluntary delisting of its common shares from the Canadian Securities Exchange (CSE).
Tag Archives: CNSX
TORONTO, Ontario, June 1, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (CSE:SL)(CSE:SL.CN)(CNSX:SL)(OTC PINK:SPRWF) is pleased to announce that it has received final approval from the TSX Venture Exchange (“TSX.V”) to list the Company’s common shares on the TSX.V. The common shares are expected to begin trading on the TSX.V at the opening of markets on June 6, 2017 under the symbol “FIRE”.
KELOWNA, British Columbia, Dec. 16, 2015 /Weed Wire/ — Lexaria Corp. (OTCQB: LXRPD) (CNSX: LXX) (the “Company” or “Lexaria”) confirms the earlier announced Lexaria forward stock split has taken place and the company’s shares begin trading on a post-split basis today at the open of trading.
KELOWNA, British Columbia, Dec. 14, 2015 /Weed Wire/ — Lexaria Corp. (OTCQB:LXRP) (CNSX: LXX) has signed an Investor Relations and media coverage services agreement with RADIUS Consulting, initially on a 45-day trial basis, to provide services.